FDA Expands Approval of Emend, a single-dose i... - CLL Support

CLL Support

22,987 members39,473 posts

FDA Expands Approval of Emend, a single-dose intravenous, (injectable) treatment for Nausea/Vomiting

AussieNeil profile image
AussieNeilPartnerAdministrator
1 Reply

I found the following informative explanation of the different phases of chemotherapy induced nausea and vomiting very helpful (per my emphasis in bold). Hopefully it will help those of us currently experiencing this common distressing side effect from treatment to know of the different phases and if you live in the States, you may even be able to access Emend via injection - very handy when you can't get anti-emetic tablets down and want fast relief!

"Chemotherapy-induced nausea and vomiting falls into two major categories—the acute phase, which occurs within 24 hours after administration of chemotherapy; and the delayed phase, which typically starts at least 24 hours after administration. Up to about 25% of patients who have received prior chemotherapy can also experience anticipatory chemotherapy-induced nausea and vomiting, a result of classic conditioning from a prior nausea or vomiting experience that typically occurs within 12 hours prior to administration of chemotherapy.

Chemotherapy-induced nausea and vomiting is a major issue for many patients receiving chemotherapy to treat their cancer. According to some studies, about 40% of patients receiving a new chemotherapy regimen develop acute nausea and vomiting, and as many as 60% of patients experience delayed symptoms."

Full announcement:

cancernetwork.com/nausea-an...

And here's a previous post about another related FDA approval for a new anti-nausea drug:

healthunlocked.com/cllsuppo...

Neil

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
Read more about...
1 Reply
Fowey2009 profile image
Fowey2009

My husband had Emend after other anti sickness medicines didn't work. They called it the Rolls Royce of anti sickness meds.

Not what you're looking for?

You may also like...

GAZYVA® (Obinutuzumab) gains TGA approval for 1st line treatment of CLL in combination with Chlorambucil in Australia

GAZYVA, a new anti-CD20 monoclonal antibody, is now Therapeutic Goods Administration (TGA)...

Venetoclax plus obinutuzumab - the first chemotherapy-free, fixed-duration first line CLL treatment approved by Health Canada

* VENCLEXTA® (venetoclax) plus obinutuzumab is the first chemotherapy-free, fixed-duration...

FDA Approves Zanubrutinib for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphom

FDA Approves Zanubrutinib for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Jan 19,...

The FDA has authorized the Emergency use of REGEN-COV for the treatment of COVID-19

For those who don't know; The FDA has authorized the emergency use of REGEN-COV for the treatment...

Venetoclax (ABT-199) Receives Breakthrough Therapy Designation In Relapsed Or Refractory CLL In Previously Treated 17p deletion Patients

This breakthrough designation - only for relapsed/refractory 17p deletion patients should mean the...